Concord Biotech IPO vs Senco Gold IPO

Comparision between Concord Biotech IPO and Senco Gold IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Senco Gold IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Concord Biotech IPO	Senco Gold IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited	Iifl Securities Ltd Ambit Private Limited SBI Capital Markets Limited
Registrar	Link Intime India Private Ltd	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Senco Gold IPO is up to ₹405.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Senco Gold IPO is ₹317.00 per share.

	Concord Biotech IPO	Senco Gold IPO
Face Value	₹1 per share	₹10 per share
Issue Price (Lower)	₹705.00 per share	₹301.00 per share
Issue Price (Upper)	₹741.00 per share	₹317.00 per share
Issue Price (Final)	₹741.00 per share	₹317.00 per share
Discount (Retail)
Discount (Employee)	₹70.00 per share
Market Lot Size	20 shares	47 shares
Fresh Issue Size		85,17,350 shares
Fresh Issue Size (Amount)		up to ₹270.00 Cr
OFS Issue Size	2,09,25,652 shares	42,58,675 shares
OFS Issue Size (Amount)	up to ₹1,551.00 Cr	up to ₹135.00 Cr
Issue Size Total	2,09,25,652 shares	1,27,76,025 shares
Issue Size Total (Amount)	up to ₹1,551.00 Cr	up to ₹405.00 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Senco Gold IPO opens on Jul 04, 2023. The closing date of Concord Biotech IPO and Senco Gold IPO is Aug 08, 2023, and Jul 06, 2023, respectively.

	Concord Biotech IPO	Senco Gold IPO
Anchor Bid Date	Aug 03, 2023	Jul 03, 2023
Issue Open	Aug 04, 2023	Jul 04, 2023
Issue Close	Aug 08, 2023	Jul 06, 2023
Basis Of Allotment (Tentative)	Aug 11, 2023	Jul 11, 2023
Initiation of Refunds (Tentative)	Aug 14, 2023	Jul 12, 2023
Credit of Share (Tentative)	Aug 17, 2023	Jul 13, 2023
Listing date (Tentative)	Aug 18, 2023	Jul 14, 2023
Anchor Lockin End date 1	Sep 10, 2023	Aug 10, 2023
Anchor Lockin End date 2	Nov 09, 2023	Oct 09, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Senco Gold IPO P/E ratio of 15.53.

Concord Biotech IPO

Senco Gold IPO

Financial

Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Amount in ₹ Crore

Senco Gold Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-21	1,559.30	2,674.92	61.48	602.51	536.53	532.44
31-Mar-22	2,100.19	3,547.41	129.10	725.77	659.46	862.97
31-Mar-23	2,905.32	4,108.54	158.48	944.97	876.27	1,177.17
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

44.08%

76.92%

Promoter Shareholding (Post-Issue)

44.08%

68.48%

P/E Ratio

32.29

15.53

Market Cap

₹7752.06 Cr.

₹2462.00 Cr.

ROE

20.06%%

18.9%%

ROCE

24.27%%

14.2%%

Debt/Equity

1.25

EPS

₹20.79

₹22.93

RoNW

20%%

18.96%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Senco Gold IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 25,55,203 shares in Senco Gold IPO.

	Concord Biotech IPO	Senco Gold IPO
Anchor Investor Reserveration	62,74,695 shares	38,32,807 shares
Market Maker Reserveration
QIB	41,83,130 shares	25,55,203 shares
NII	31,37,348 shares	19,16,404 shares
RII	73,20,479 shares	44,71,609 shares
Employee	10,000 shares	0 shares
Others
Total	1,46,50,957 shares	89,43,216 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Senco Gold IPO subscribed 77.25x.

	Concord Biotech IPO	Senco Gold IPO
QIB (times)	67.67x	190.56x
NII (times)	16.99x	68.44x
Big NII (times)	19.30x	72.05x
Small NII (times)	12.37x	61.23x
RII (times)	3.78x	16.28x
Employee (times)	24.48x
Other (times)
Total (times)	24.87x	77.25x

Compare with others

Concord Biotech IPO	Senco Gold IPO
Aeroflex Industries IPO	Concord Biotech IPO
Pyramid Technoplast IPO	SBFC Finance IPO
India Shelter Finance IPO	Yatharth Hospital IPO
Balaji Speciality Chemicals IPO	Netweb Technologies India IPO
TVS Supply Chain Solutions IPO	Utkarsh Small Finance Bank IPO
SBFC Finance IPO	Cyient DLM IPO
Yatharth Hospital IPO	ideaForge Technology IPO
Netweb Technologies India IPO	HMA Agro Industries IPO
Utkarsh Small Finance Bank IPO	IKIO Lighting IPO
Senco Gold IPO	Tata Technologies IPO

Comments

Add a public comment...